GlassScriptPhysician profile
Monica Davis
NPI 1790468312
$1,462.75
in general payments reported to CMS, 2019-2025
14 companies · $728 in 2025
The $728 reported for 2025 was more than what 92% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Obstetrics & Gynecology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $46.25 · 2024: $689 · 2025: $728.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,462.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $300.09 | 2024-2025 | |
| Mayne Pharma Commercial LLC | $291.87 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $174.89 | 2024-2025 | Myfembree |
| Evofem Biosciences, INC. | $145.79 | 2023-2025 | Phexxi, Solosec, Phexx |
| Daiichi Sankyo INC. | $125.00 | 2024 | Injectafer |
| Organon LLC | $122.69 | 2023-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $78.20 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Astellas Pharma US INC | $56.66 | 2024-2025 | Veozah |
| Coopersurgical, INC. | $47.50 | 2025 | Paragard T 380a |
| Davol INC. | $35.84 | 2024 | Arista Ah Flexitip |
| Agile Therapeutics, INC. | $24.49 | 2024 | Twirla |
| Exeltis, USA INC. | $20.89 | 2024 | Slynd |
| Sage Therapeutics, LLC | $19.42 | 2025 | Zurzuvae |
| Supernus Pharmaceuticals, INC. | $19.42 | 2025 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.